NCT04201665View on ClinicalTrials.gov

EMG for Uterotonic Efficiency Estimation

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 13, 2020

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Postpartum Hemorrhage
Interventions
DRUG

Carbetocin

Patients will receive a single dose of carbetocin 100 mcg (Pabal ®) at admission to high dependency obstetric unit after cesarean section.

DRUG

Oxytocin

Patients will receive 5 units of oxytocin ( Syntocinon ®) as a 250 ml 0.9% NaCl infusion at admission to high dependency obstetric unit after cesarean section.

Trial Locations (1)

Unknown

UMC Ljubljana, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER

NCT04201665 - EMG for Uterotonic Efficiency Estimation | Biotech Hunter | Biotech Hunter